264 related articles for article (PubMed ID: 6158934)
21. The relationship of soluble immune complexes, insulin antibodies and insulin-anti-insulin complexes to platelet and coagulation factors in type 1 diabetic patients with and without proliferative retinopathy.
Di Mario U; Borsey DQ; Contreas G; Prowse CV; Clarke BF; Andreani D
Clin Exp Immunol; 1986 Jul; 65(1):57-65. PubMed ID: 2947762
[TBL] [Abstract][Full Text] [Related]
22. Enhanced "in vitro" release of platelet alpha-granules after acute myocardial infarction (AMI).
Pengo V; Boschello M; Prandoni P; Schiavon R; Bellotto F; Schivazappa L; Dalla Volta S
Thromb Haemost; 1985 Aug; 54(2):544-6. PubMed ID: 2934859
[TBL] [Abstract][Full Text] [Related]
23. Increased releasability of platelet products and reduced heparin-induced platelet factor 4 release from endothelial cells in bronchial asthma.
Yasuba H; Chihara J; Kino T; Satake N; Oshima S
J Lipid Mediat; 1991; 4(1):5-21. PubMed ID: 1832572
[TBL] [Abstract][Full Text] [Related]
24. Intra-platelet platelet factor 4 (IP.PF4) and the heparin-mobilisable pool of PF4 in health and atherosclerosis.
O'Brien JR; Etherington MD; Pashley M
Thromb Haemost; 1984 Jul; 51(3):354-7. PubMed ID: 6495255
[TBL] [Abstract][Full Text] [Related]
25. Serial determinations of PF4 and beta TG: comparisons between multiple venipunctures vs a catheter infusion system.
Strauss W; Cella G; Myers C; Sasahara AA
Thromb Haemost; 1988 Jun; 59(3):491-4. PubMed ID: 2973152
[TBL] [Abstract][Full Text] [Related]
26. Platelet aggregation and plasma levels of beta-thromboglobulin in diabetes mellitus.
Yamada K; Mori K; Goto Y
Tohoku J Exp Med; 1981 Dec; 135(4):423-9. PubMed ID: 6175049
[TBL] [Abstract][Full Text] [Related]
27. Secreted platelet proteins with antiheparin and mitogenic activities in chronic renal failure.
Guzzo J; Niewiarowski S; Musial J; Bastl C; Grossman RA; Rao AK; Berman I; Paul D
J Lab Clin Med; 1980 Jul; 96(1):102-13. PubMed ID: 6446588
[TBL] [Abstract][Full Text] [Related]
28. beta-Thromboglobulin--a specific marker of in-vivo platelet release reaction.
Zahavi J; Kakkar VV
Thromb Haemost; 1980 Aug; 44(1):23-9. PubMed ID: 6158764
[No Abstract] [Full Text] [Related]
29. [Evaluation of thrombotic risk in type 2 diabetes: determination of platelet factor 4 and beta thromboglobulin].
Diop S; Ka-Cisse M; Toure-Fall AO; Diagne Fall-Sarr F; Diop SN; Thiam D; Diakhate L
Dakar Med; 2002; 47(2):247-51. PubMed ID: 15776686
[TBL] [Abstract][Full Text] [Related]
30. Platelets and diabetic vascular disease.
Paton RC; Passa P
Diabete Metab; 1983 Dec; 9(4):306-12. PubMed ID: 6230270
[TBL] [Abstract][Full Text] [Related]
31. Ex vivo platelet studies following oral nisoldipine in normotensive insulin-dependent diabetics and non-diabetic controls.
Hendra TJ; Oughton J; Jeremy JY; Smith CC; Betteridge DJ; Dandona P; Yudkin JS
Diabetes Res; 1988 Jul; 8(3):117-22. PubMed ID: 2976336
[TBL] [Abstract][Full Text] [Related]
32. Platelet activation in response to phlebotomy. An experimental study of healthy blood donors.
Eriksson KA; Sigvaldason A; Lindholm A; Safai-Kutti S; Kutti J
Acta Med Scand; 1982; 212(3):121-3. PubMed ID: 6183925
[TBL] [Abstract][Full Text] [Related]
33. Activation of platelets in patients with chronic proliferative glomerulonephritis and the nephrotic syndrome.
Tomura S; Ida T; Kuriyama R; Chida Y; Takeuchi J; Motomiya T; Yamazaki H
Clin Nephrol; 1982 Jan; 17(1):24-30. PubMed ID: 6459902
[TBL] [Abstract][Full Text] [Related]
34. Standardization of beta-thromboglobulin and platelet factor 4: a collaborative study to investigate the sources and extent of variation in the measurement of platelet specific proteins.
Curtis AD; Kerry PJ
Thromb Haemost; 1983 Oct; 50(3):686-9. PubMed ID: 6196853
[TBL] [Abstract][Full Text] [Related]
35. Relationship between low affinity platelet factor 4 (LA-PF4) and beta-thromboglobulin (beta TG).
Niewiarowski S
Thromb Haemost; 1980 Aug; 44(1):47. PubMed ID: 6158765
[No Abstract] [Full Text] [Related]
36. The assessment of platelet function in vivo by measurement of beta-thromboglobulin, platelet factor 4 and platelet survival.
Ludlam CA
Artery; 1980; 8(5):470-4. PubMed ID: 6163418
[TBL] [Abstract][Full Text] [Related]
37. Plasma levels of betathromboglobulin and platelet factor 4 in peripheral vascular disease.
Blättler W; Diener R; Haeberli A; Straub PW
Vasa Suppl; 1984; 12():75-80. PubMed ID: 6207678
[No Abstract] [Full Text] [Related]
38. Platelet function in sickle cell disease during steady state.
Triadou P; Fonty E; Ambrosio AS; Cottat MC; Girot R; Cornu P
Nouv Rev Fr Hematol (1978); 1990; 32(2):137-42. PubMed ID: 2143013
[TBL] [Abstract][Full Text] [Related]
39. [Changes of beta-thromboglobulin levels in diabetic patients controlled with the artificial pancreas].
Voisin P; Rousselle D; Drouin P; Stoltz JF
Biomed Pharmacother; 1982 Jan; 36(1):19-23. PubMed ID: 6181821
[TBL] [Abstract][Full Text] [Related]
40. Platelet activation in myeloproliferative disorders.
Cortelazzo S; Viero P; Barbui T
Thromb Haemost; 1981 Jun; 45(3):211-3. PubMed ID: 6169172
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]